Large-scale testing (Phase 3)Study completedNCT03769168
What this trial is testing
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Novartis Pharmaceuticals 55